Everest Secures Exclusive Rights to Obinutuzumab Beta Across Key Asia-Pacific Markets
Everest Secures Exclusive Rights to Sumecigrel (Vicagrel) Across Multiple Asia-Pacific Markets
Zai Lab ：TIVDAK®Tisotumab vedotinapproved for marketing in China.
Tasly ：rhPro-UK Phase II Data for Pulmonary Embolism Released
Remegen ：Telitacicept receives approval for dual indications.
Teva ：AJOVY®Fremanezumab-vfrmapproved for marketing in China.
Roche ：bexobrutideg has been in-licensed for development
Zenshine ：Jikeshu®Sebaloxavir Marboxil Tablets approved for marketing in China.
How much does Amaryl (Glimepiride Tablets) Cost& price without insurance in China?
How much does Yunzhi (Colchicine Tablets) Cost& price without insurance in China?
